|
1
|
Machtay M and Jeremic B: Complex and
controversial issues in locally advanced non-small cell lung
carcinoma. Semin Surg Oncol. 21:128–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stanley K and Stjernswärd J: Lung cancer-a
worldwide health problem. Chest. 96(Suppl 1): S1–S5. 1989.
View Article : Google Scholar
|
|
3
|
Thatcher N: New perspectives in lung
cancer. 4 Haematopoietic growth factors and lung cancer treatment.
Thorax. 47:119–126. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weynants P, Marchandise FX and Sibille Y:
Pulmonary perspective: Immunology in diagnosis and treatment of
lung cancer. Eur Respir J. 10:1703–1719. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yao Z, Fanslow WC, Seldin MF, Rousseau AM,
Painter SL, Comeau MR, Cohen JI and Spriggs MK: Herpes virus
Saimiri encodes a new cytokine, IL-17, which binds to a novel
cytokine receptor. Immunity. 3:811–821. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Starnes T, Robertson MJ, Sledge G, Kelich
S, Nakshatri H, Broxmeyer HE and Hromas R: IL-17F, a novel cytokine
selectively expressed in activated T cells and monocytes, regulates
angiogenesis and endothelial cell cytokine production. J Immunol.
167:4137–4140. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hymowitz SG, Filvaroff EH, Yin JP, Lee J,
Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, et al:
IL-17s adopt a cystine knot fold: Structure and activity of a novel
cytokine, IL-17F and implications for receptor binding. EMBO J.
20:5332–5341. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Antonysamy MA and Numasaki M:
Interleukin-17 (IL-17, IL-25) In The Cytokine Handbook, 4th Ed A W
Thomson and M T Lotze, eds. Academic Press; London: pp. 475–502.
2003
|
|
9
|
Fossiez F, Djossou O, Chomarat P,
Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E,
Saeland S, et al: T cell interleukin-17 induces stromal cells to
produce proinflammatory and hematopoietic cytokines. J Exp Med.
183:2593–2603. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yao Z, Painter SL, Fanslow WC, Ulrich D,
Macduff BM, Spriggs MK and Armitage RJ: Human IL-17: A novel
cytokine derived from T cells. J Immunol. 155:5483–5486.
1995.PubMed/NCBI
|
|
11
|
Numasaki M, Tomioka Y, Takahashi H and
Sasaki H: IL-17 and IL-17F modulate GM-CSF production by lung
microvascular endothelial cells stimulated with IL-1beta and/or
TNF-alpha. Immunol Lett. 95:175–184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Numasaki M, Takahashi H, Tomioka Y and
Sasaki H: Regulatory roles of IL-17 and IL-17F in G-CSF production
by lung microvascular endothelial cells stimulated with IL-1beta
and/or TNF-alpha. Immunol Lett. 95:97–104. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Numasaki M, Lotze MT and Sasaki H:
Interleukin-17 augments tumor necrosis factor-alpha-induced
elaboration of proangiogenic factors from fibroblasts. Immunol
Lett. 93:39–43. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aarvak T, Chabaud M, Miossec P and Natvig
JB: IL-17 is produced by some proinflammatory Th1/Th0 cells but not
by Th2 cells. J Immunol. 162:1246–1251. 1999.PubMed/NCBI
|
|
15
|
Yao Z, Spriggs MK, Derry JM, Strockbine L,
Park LS, VandenBos T, Zappone JD, Painter SL and Armitage RJ:
Molecular characterization of the human interleukin (IL)-17
receptor. Cytokine. 9:794–800. 1997. View Article : Google Scholar
|
|
16
|
Kotake S, Udagawa N, Takahashi N,
Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N,
Gillespie MT, et al: IL-17 in synovial fluids from patients with
rheumatoid arthritis is a potent stimulator of osteoclastgenesis. J
Clin Invest. 103:1345–1352. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chabaud M, Lubberts E, Joosten L, van Den
Berg W and Miossec P: IL-17 derived from juxta-articular bone and
synovium contributes to joint degradation in rheumatoid arthritis.
Arthritis Res. 3:168–177. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Antonysamy MA, Fanslow WC, Fu F, Li W,
Qian S, Troutt AB and Thomson AW: Evidence for a role of IL-17 in
organ allograft rejection: IL-17 promotes the functional
differentiation of dendritic cell progenitors. J Immunol.
162:577–584. 1999.PubMed/NCBI
|
|
19
|
Teunissen MB, Koomen CW, de Waal Malefyt
R, Wierenga EA and Bos JD: Interleukin-17 and interferon-gamma
synergize in the enhancement of proinflammatory cytokine production
by human keratinocytes. J Invest Dermatol. 111:645–649. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Molet S, Hamid Q, Davoine F, Nutku E, Taha
R, Pagé N, Olivenstein R, Elias J and Chakir J: IL-17 is increased
in asthmatic airways and induces human bronchial fibroblasts to
produce cytokines. J Allergy Clin Immunol. 108:430–438. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang B, Kang H, Fung A, Zhao H, Wang T and
Ma D: The role of interleukin 17 in tumour proliferation,
angiogenesis, and metastasis. Mediators Inflamm. 2014:6237592014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murugaiyan G and Saha B: Protumor vs
antitumor functions of IL-17. J Immunol. 183:4169–4175. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miyahara Y, Odunsi K, Chen W, Peng G,
Matsuzaki J and Wang RF: Generation and regulation of human CD4+
IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA.
105:15505–15510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang JP, Yan J, Xu J, Pang XH, Chen MS,
Li L, Wu C, Li SP and Zheng L: Increased intratumoral
IL-17-producing cells correlate with poor survival in
hepatocellular carcinoma patients. J Hepatol. 50:980–989. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Numasaki M, Watanabe M, Suzuki T,
Takahashi H, Nakamura A, McAllister F, Hishinuma T, Goto J, Lotze
MT, Kolls JK and Sasaki H: IL-17 enhances the net angiogenic
activity and in vivo growth of human non-small cell lung cancer in
SCID mice through promoting CXCR-2-dependent angiogenesis. J
Immunol. 175:6177–6189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin L, Chen YS, Yao YD, Chen JQ, Chen JN,
Huang SY, Zeng YJ, Yao HR, Zeng SH, Fu YS and Song EW: CCL18 from
tumor-associated macrophages promotes angiogenesis in breast
cancer. Oncotarget. 6:34758–34773. 2015.PubMed/NCBI
|
|
27
|
Dobrzycka B, Mackowiak-Matejczyk B,
Kinalski M and Terlikowski SJ: Pretreatment serum levels of bFGF
and VEGF and its clinical significance in endometrial carcinoma.
Gynecol Oncol. 128:454–460. 2013. View Article : Google Scholar
|
|
28
|
Park H, Li Z, Yang XO, Chang SH, Nurieva
R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct
lineage of CD4 T cells regulates tissue inflammation by producing
interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Numasaki M, Fukushi J, Ono M, Narula SK,
Zavodny PJ, Kudo T, Robbins PD, Tahara H and Lotze MT:
Interleukin-17 promotes angiogenesis and tumor growth. Blood.
101:2620–2627. 2003. View Article : Google Scholar
|
|
30
|
Kato T, Furumoto H, Ogura T, Onishi Y,
Irahara M, Yamano S, Kamada M and Aono T: Expression of IL-17 mRNA
in ovarian cancer. Biochem Biophys Res Commun. 282:735–738. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reppert S, Boross I, Koslowski M, Türeci
Ö, Koch S, Lehr HA and Finotto S: A role for T-bet-mediated tumour
immune surveillance in anti-IL-17A treatment of lung cancer. Nat
Commun. 2:6002011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Duan MC, Zhong XN, Liu GN and Wei JR: The
Treg/Th17 paradigm in lung cancer. J Immunol Res. 2014:7303802014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iida T, Iwahashi M, Katsuda M, Ishida K,
Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, et al:
Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor
microenvironment and promote tumor progression in human gastric
cancer. Oncol Rep. 25:1271–1277. 2011.PubMed/NCBI
|
|
34
|
Chae WJ, Gibson TF, Zelterman D, Hao L,
Henegariu O and Bothwell AL: Ablation of IL-17A abrogates
progression of spontaneous intestinal tumorigenesis. Proc Natl Acad
Sci USA. 107:5540–5544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Charles KA, Kulbe H, Soper R,
Escorcio-Correia M, Lawrence T, Schultheis A, Chakravarty P,
Thompson RG, Kollias G, Smyth JF, et al: The tumor-promoting
actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in
mice and humans. J Clin Invest. 119:3011–3023. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ichinose Y, Yano T, Asoh H, Yokoyama H,
Yoshino I and Katsuda Y: Prognostic factors obtained by a
pathologic examination in completely resected non-small-cell lung
cancer. An analysis in each pathologic stage. J Thorac Cardiovasc
Surg. 110:601–605. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
van Velzen E, Snijder RJ, Brutel de la
Rivière A, Elbers HJ and van den Bosch JM: Type of lymph node
involvement influences survival rates in T1N1M0 non-small cell lung
carcinoma. Lymph node involvement by direct extension compared with
lobar and hilar node metastases. Chest. 110:1469–1473. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mountain CF and Dresler CM: Regional lymph
node classification for lung cancer staging. Chest. 111:1718–1723.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sierra-Filardi E, Nieto C, Domínguez-Soto
A, Barroso R, Sánchez-Mateos P, Puig-Kroger A, López-Bravo M, Joven
J, Ardavín C, Rodríguez-Fernández JL, et al: CCL2 shapes macrophage
polarization by GM-CSF and M-CSF: Identification of
CCL2/CCR2-dependent gene expression profile. J Immunol.
192:3858–3867. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mitchem JB, Brennan DJ, Knolhoff BL, Belt
BA, Zhu Y, Sanford DE, Belaygorod L, Carpenter D, Collins L,
Piwnica-Worms D, et al: Targeting tumor-infiltrating macrophages
decreases tumor-initiating cells, relieves immunosuppression, and
improves chemotherapeutic responses. Cancer Res. 73:1128–1141.
2013. View Article : Google Scholar :
|
|
41
|
Chen X, Wan J, Liu J, Xie W, Diao X, Xu J,
Zhu B and Chen Z: Increased IL-17-producing cells correlate with
poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer.
69:348–354. 2010. View Article : Google Scholar
|
